Abstract
Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have